tiprankstipranks
Advertisement
Advertisement
Alector price target raised to $2 from 90c at Morgan Stanley
PremiumThe FlyAlector price target raised to $2 from 90c at Morgan Stanley
2M ago
Alector to discontinue PROGRESS-AD trial of nivisnebart
Premium
The Fly
Alector to discontinue PROGRESS-AD trial of nivisnebart
2M ago
Alector upgraded to Overweight from Neutral at Cantor Fitzgerald
Premium
The Fly
Alector upgraded to Overweight from Neutral at Cantor Fitzgerald
3M ago
Alector: Holding Amid Pipeline Setback as ABC Brain Delivery Platform Awaits Clinical Validation
PremiumRatingsAlector: Holding Amid Pipeline Setback as ABC Brain Delivery Platform Awaits Clinical Validation
4M ago
Alector reports Q4 EPS (34c), consensus (36c)
Premium
The Fly
Alector reports Q4 EPS (34c), consensus (36c)
4M ago
Alector Ends Latozinemab Continuation Study: Reading the Signals for ALEC Investors
Premium
Company Announcements
Alector Ends Latozinemab Continuation Study: Reading the Signals for ALEC Investors
5M ago
Alector price target lowered to 75c from $1.50 at Morgan Stanley
PremiumThe FlyAlector price target lowered to 75c from $1.50 at Morgan Stanley
8M ago
Alector’s Strategic and Financial Challenges Prompt Sell Rating Amid Clinical Setbacks
Premium
Ratings
Alector’s Strategic and Financial Challenges Prompt Sell Rating Amid Clinical Setbacks
8M ago
Alector’s Strategic Shift to ABC Platform: Promising CNS Delivery and Neurodegenerative Disease Solutions
Premium
Ratings
Alector’s Strategic Shift to ABC Platform: Promising CNS Delivery and Neurodegenerative Disease Solutions
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100